{"id":"W2980052436","doi":"10.1182/blood.v128.22.4018.4018","title":"Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Regimen; Minimal residual disease; Internal medicine; Salvage therapy; Refractory (planetary science); Gastroenterology; Vincristine; Cyclophosphamide; Surgery; Immunology; Leukemia; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001938012,0.0008035877,0.001550958,0.0003070075,0.0002067605,0.0005383542,0.0005464343,0.0004855613,0.001125521],"category_scores_gemma":[0.0006697634,0.0002718893,0.0008907363,0.0003618169,0.0004823648,0.0004866263,0.0002887562,0.001518927,0.0002851885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006201453,"about_ca_system_score_gemma":0.0007477301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008112441,"about_ca_topic_score_gemma":0.001535493,"domain_scores_codex":[0.9994555,0.0003138833,0.00003164161,0.00007284094,0.00005758315,0.00006857185],"domain_scores_gemma":[0.9993363,0.0001539405,0.0001307874,0.00007767652,0.00003168866,0.0002695713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5399412,0.06677539,0.06607158,0.001086789,0.003501085,0.0009449896,0.000873117,0.004535349,0.07145489,0.0002788478,0.002469065,0.2420677],"study_design_scores_gemma":[0.1283034,0.740073,0.1146238,0.00006798917,0.002097749,0.001404634,0.0001424181,0.001460957,0.007688659,0.0001400652,0.003959576,0.00003776931],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982809,0.0009669128,0.0001075219,0.00005461515,0.00001187861,0.000151451,0.0001733681,0.00001007193,0.0002434224],"genre_scores_gemma":[0.9967054,0.001258466,0.0003382664,0.0002335224,0.00006617514,0.000193605,0.0007648898,0.000009057702,0.0004306006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001938012,"threshold_uncertainty_score":0.01024932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0142154641662634,"score_gpt":0.2907732417268465,"score_spread":0.2765577775605831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}